Related Experiment Video
Updated: Aug 6, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Heterogeneity-based genome search meta-analysis for preeclampsia
Elias Zintzaras1, Georgios Kitsios, Gavan A Harrison
1Department of Biomathematics, University of Thessaly School of Medicine, Papakyriazi 22, Larissa, 41222, Greece. zintza@med.uth.gr
Human Genetics
|July 27, 2006
Summary
This study used a novel meta-analysis to identify potential genetic regions linked to preeclampsia. Findings highlight specific chromosomal bins requiring further investigation for understanding this complex pregnancy disorder.
Area of Science:
- Genetics
- Obstetrics & Gynecology
- Genomic Medicine
Background:
- Preeclampsia is a significant cause of maternal and fetal complications.
- The genetic basis of preeclampsia remains largely unknown.
- Previous genome searches have yielded inconsistent results.
Purpose of the Study:
- To synthesize existing genome scan data for preeclampsia using a heterogeneity-based genome search meta-analysis (HEGESMA).
- To identify specific genetic regions (bins) associated with preeclampsia susceptibility.
- To provide a refined focus for future genetic research into preeclampsia.
Main Methods:
- Performed a meta-analysis combining data from four genome scans for general preeclampsia and five for severe preeclampsia.
- Utilized HEGESMA to identify genetic bins with high average linkage statistics and assessed heterogeneity across scans.
- Employed Monte Carlo tests to determine the statistical significance of bin ranks and heterogeneity.
Main Results:
- Identified 13 significant bins for general preeclampsia, with four (2p11.2-2q21.1, 9q21.32-9q31.2, 2p15-2p11.2, 2q32.1-2q35) being formally significant by both analyses.
- Observed significantly low heterogeneity for bin 2q32.1-2q35 in general preeclampsia.
- Detected 10 significant bins for severe preeclampsia, with five (3q11.1-3q21.2, 2q37.1-2q37.3, 18p11.32-18p11.22, 2p15-2p11.2, 7q34-7q36.3) being formally significant by both analyses.
Conclusions:
- The study identified several promising genetic regions associated with preeclampsia susceptibility.
- Low heterogeneity in certain bins suggests potentially consistent genetic effects.
- Further genotyping in these regions is recommended to pinpoint candidate genes for preeclampsia, though results should be interpreted cautiously due to modest p-values.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...